We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

120 hedge funds and large institutions have $580M invested in Collegium Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 48 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $319K

18% more capital invested

Capital invested by funds: $492M → $580M (+$88.3M)

0.9% more ownership

Funds ownership: 100.74% → 101.64% (+0.9%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 124 → 120 (-4)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

17% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 48

Holders
120
Holders Change
-4
Holders Change %
-3.23%
% of All Funds
2.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
40
Reduced
48
Closed
19
Calls
$1.2M
Puts
$319K
Net Calls
+$876K
Net Calls Change
-$4.3M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$20M
2
PA
Perceptive Advisors
New York
+$7.61M
3
RHJA
Rice Hall James & Associates
California
+$6.27M
4
UBS AM
UBS AM
Illinois
+$5.01M
5
Macquarie Group
Macquarie Group
Australia
+$3.79M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$14.2M
2
JGC
J. Goldman & Co
New York
-$8.81M
3
Morgan Stanley
Morgan Stanley
New York
-$8.16M
4
MC
Maverick Capital
Texas
-$6.22M
5
Two Sigma Investments
Two Sigma Investments
New York
-$3.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
51
Manchester Capital Management
Vermont
$787K – – –
Deutsche Bank
52
Deutsche Bank
Germany
$725K -$602K -35,167 -45%
Swiss National Bank
53
Swiss National Bank
Switzerland
$706K +$53K +3,100 +8%
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$670K +$213K +12,477 +47%
GIP
55
Granite Investment Partners
California
$663K +$230K +13,467 +54%
NC
56
NBW Capital
Massachusetts
$648K -$6.45K -377 -1%
Barclays
57
Barclays
United Kingdom
$648K +$457K +26,688 +242%
HI
58
HBK Investments
Texas
$643K +$641K +37,451 New
Fisher Asset Management
59
Fisher Asset Management
Washington
$614K – – –
SO
60
STRS Ohio
Ohio
$612K -$258K -15,100 -30%
MPAM
61
Monarch Partners Asset Management
Massachusetts
$580K +$92.9K +5,430 +19%
TI
62
Trexquant Investment
Connecticut
$568K -$19K -1,111 -3%
Bessemer Group
63
Bessemer Group
New Jersey
$555K +$553K +32,300 New
T. Rowe Price Associates
64
T. Rowe Price Associates
Maryland
$549K -$176K -10,265 -24%
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$522K +$8.55K +500 +2%
MCM
66
Matarin Capital Management
New York
$485K +$484K +28,270 New
Commonwealth Equity Services
67
Commonwealth Equity Services
Massachusetts
$482K -$12.8K -750 -3%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$470K -$90.7K -5,300 -16%
CS
69
Credit Suisse
Switzerland
$445K +$86K +5,029 +24%
Bank of America
70
Bank of America
North Carolina
$412K +$60.3K +3,525 +17%
Two Sigma Advisers
71
Two Sigma Advisers
New York
$391K -$140K -8,200 -26%
Royal Bank of Canada
72
Royal Bank of Canada
Ontario, Canada
$373K -$85.3K -4,988 -19%
LCM
73
Landscape Capital Management
New Jersey
$349K +$347K +20,309 New
AIG
74
American International Group
New York
$332K -$2.53K -148 -0.8%
SEI Investments
75
SEI Investments
Pennsylvania
$316K +$318K +18,566 +38,679%
1 2
3
4 5

COLL Hedge Fund Activity: Q4 2018 in Review

120 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2018, worth a combined $580M — up 18% from $492M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of COLL and 16 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 40 added.

The largest buyer was Millennium Management, adding an estimated $20M. The largest seller was Sectoral Asset Management, cutting an estimated $14.2M.

  • 120 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2018, down from 124 in Q3 2018.
  • Funds reported $580M of Collegium Pharmaceutical stock for Q4 2018, up 18% quarter-over-quarter.
  • 16 funds opened new Collegium Pharmaceutical positions in Q4 2018 and 19 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2018 was Millennium Management, an estimated $20M added.
  • The largest Collegium Pharmaceutical seller in Q4 2018 was Sectoral Asset Management, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2018.